Quarry LP’s Lexicon Pharmaceuticals LXRX Stock Holding History

Quarry LP’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$172K	Buy	110,000 +22,000	+25%	+$32K	0.03%	364
2025 Q4	$101K	Buy	+88,000	New	+$121K	0.02%	442

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Quarry LP's LXRX Position: Q1 2026 in Review

Quarry LP increased its Lexicon Pharmaceuticals (LXRX) stake by 25% in Q1 2026, buying an estimated $32K and bringing the position to 110,000 shares worth $172K. The position accounts for 0.03% of the portfolio, ranked #364.

Quarry LP first reported a position in LXRX in Q4 2025 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold LXRX as of Q1 2026.

Quarry LP held 110,000 shares of Lexicon Pharmaceuticals worth $172K as of Q1 2026.
Quarry LP bought 22,000 Lexicon Pharmaceuticals shares in Q1 2026, an estimated $32K.
Lexicon Pharmaceuticals made up 0.03% of Quarry LP's portfolio in Q1 2026, its #364 holding.
Quarry LP first reported a position in Lexicon Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
136 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.